via NEWMEDIAWIRE — CaliPharms, Inc. (OTCPink:KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol “KGET” is pleased to announce they will debut its new CBD Muscle & Joint Relief Roll On Gel at the Marijuana Business Conference (MJBizCon) this week November 14-16th at the Las Vegas Convention Center in Las Vegas, Nevada.
MJBizCon has been running for over 5 years, and was recognized as the fastest-growing trade show in the country across all industries in 2016. MJBizCon, a semi-annual, all-professional trade show, attracts not only the largest, but the most-qualified buying audience of any cannabis event in America. Over 20,000+ cannabis professionals are expected to attend along with over 1,000+ exhibitors, making this the preeminent event for industry professionals. Learn more at www.mjbizconference.com
One of CaliPharms’ chief consultants Joe Pavlik, a product development specialist in the health, beauty and fitness industry, will be attending the show to present the new CBD Muscle & Joint Relief Roll On Gel to distributors, retailers and former professional athletes. CaliPharms’ new CBD Muscle & Joint Relief Roll On Gel was specially formulated with THC Free CBD and natural plant extracts to deliver temporary relief of muscle and joint discomfort associated with common daily activities, and also can help athletes and weekend warriors get through workouts!
Mr. Pavlik stated: “This show provides an excellent end of the year opportunity to present new products and services to a large qualified buying audience, that is looking for and appreciates innovations in new CBD product technology.” Pavlik continued, “I’m looking forward to the response on the new CBD products and delivery methods, and eager to hear the needs and requests of distributors and retailers as they have their finger on the pulse of what their customers need and are asking for. We are set up on the raw material and manufacturing side to move swiftly with any requests to deliver new CBD product formulas with novel delivery technologies in just a few weeks.”
Mr. Pavlik is the Principal and Founder of Elevate Hemp Sciences (EHS), a full service research, product development and manufacturing firm based in Fort Lauderdale, Florida focusing on the creation and innovation of CBD and hemp based products for health, beauty, wellness and athletic performance. Founded in 2012, Elevate Hemp Sciences specializes in the manufacturing of a wide variety of CBD products including oils. powders, capsules, gummies, vapes skin care, beauty and cosmetics. To learn more please visit ElevateHempSciences.com.
Accounting Note: CaliPharms’ CFO has been temporarily evacuated and displaced due to the recent California fires, therefore the 3rd quarter accounting may be a couple days late to upload on the OTC Markets website.
About CaliPharms, Inc.
CaliPharms Inc., trading under the symbol (KGET) which trades under its former name Kleangas Energy Technologies, Inc. is a development stage business. The Company currently is focused within the THC and CBD Beverage Industry.
Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as CaliPharms or KGET or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Investment into a microcap company is a high risk investment and it should only be considered if you are able to afford a total loss of the investment. Laws and Regulations of Marijuana are currently in direct contradiction between California and Federal Law and these factors should be a part of your consideration when making an investment into KGET.
CaliPharms, Inc. (KGET)
<img src=”http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzc0MzE1Mjk=” alt=”” width=”1″ height=”1″/>